drugset / Trial / NCT01838967

A Drug Interaction Study of Cilnidipine and Valsartan

NCT01838967

Phase 1 Completed 54 enrolled IlDong Pharmaceutical Co Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The investigators investigate the potential pharmacokinetic drug-drug interaction between Cilnidipine 10 mg and Valsartan 160 mg in healthy male volunteers who receive Cilnidipine 10 mg alone, Valsartan 160 mg , and both together in a 3 period repeatedly.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilnidipine Small molecule 10 mg Oral
Subject Valsartan Small molecule 160 mg Oral

Indications

No indication recorded.